glp-1 nausea mechanism glp 1 Comparing the anorexigenic effects and mechanisms of gut-derived and its receptor agonists: insights into incretin-based therapies for obesity Current Insights, Advantages and Challenges

Description

Novo Nordisk is evaluating a long-acting semaglutide implant designed to keep GLP-1 patients on treatment for months at a time and food and drink manufacturers should be watching closely.

Refills announces its clinician-led telehealth platform offering GLP-1 weight loss treatments and everyday health solutions

Purpose of Review There has been a rise in popularity and use of GLP-1 receptor agonists since their approval for obesity management

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth companies quickly added programs to prescribe anti-obesity drugs